Precision medicine
2 known investors
ViaNautis develops polyNaut, a polymer-based nanovesicle delivery system for cell and gene therapy targeting the central nervous system, lung, and immune system. The platform enables targeted genetic therapies with simplified manufacturing and improved tolerability for patients.